↓ Skip to main content

Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States

Overview of attention for article published in Diabetes Technology & Therapeutics, February 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 2,061)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
13 news outlets

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
Published in
Diabetes Technology & Therapeutics, February 2024
DOI 10.1089/dia.2023.0453
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 3 13%
Other 2 8%
Student > Postgraduate 2 8%
Unspecified 1 4%
Lecturer 1 4%
Other 3 13%
Unknown 12 50%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 7 29%
Unspecified 1 4%
Environmental Science 1 4%
Computer Science 1 4%
Engineering 1 4%
Other 0 0%
Unknown 13 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 93. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2026.
All research outputs
#570,272
of 34,306,620 outputs
Outputs from Diabetes Technology & Therapeutics
#47
of 2,061 outputs
Outputs of similar age
#8,802
of 440,608 outputs
Outputs of similar age from Diabetes Technology & Therapeutics
#2
of 40 outputs
Altmetric has tracked 34,306,620 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,061 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,608 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.